Philip Morris International

Designing a 
Smoke-Free Future

How long will PMI be in the cigarette business?

READ MORE

Why can't we talk about our better alternatives?

Learn more

Unsmoke Your World

Read more
Our CEO Andre Calantzopoulos was interviewed by the #BBC's @stephensackur on @BBCHARDtalk, where he answered questions about @InsidePMI’s...
“We are totally focused on the new products and we want to phase out cigarettes. And if governments and regulators play the game, we can ...
All News
s-i-home
Science & Innovation

Pioneering the way to a smoke-free future

We're at the forefront of developing less harmful alternatives to cigarettes.

Read more

 

This site is operated for the purpose of providing general information about us. The site is not operated for advertising or marketing purposes. The material on this site should not be regarded as an offer to sell, or a solicitation of an offer to buy, any product of PMI. Such products are sold only in compliance with the laws of the particular jurisdictions in which they are sold. IQOS and other smoke-free products under development by PMI are not currently available in the U.S. . PMI has now been granted authorization to market IQOS 2.4 in the U.S. from the Food and Drug Administration (FDA), which Altria will bring to the U.S. market under the terms of a license from PMI. The FDA has not yet determined whether IQOS 2.4 meets the standard to be marketed in the U.S. as a modified risk tobacco product.  PMI’s applications to the FDA seeking authorization to market IQOSin the U.S. as a modified risk product are currently under review.